advertisement
 |
|
Top Stories
Walmsley will succeed Andrew Witty as CEO of the British drug maker.
/ read more /
The agency granted accelerated approval to Sarepta's controversial DMD treatment, under the condition the company conduct additional studies to demonstrate efficacy.
/ read more /
|
|
|
Subscribe
Subscribers can enjoy each full issue of Pharm Tech in print, or via Pharm Tech apps.
subscription offers |
 |
|
|
|
advertisement
 |
|
Industry News
EMA has recommended halting supply of non-critical drugs from Pharmaceutics International Inc. because of GMP failures.
/ read more /
In response to the EpiPen pricing scandal, Janet Woodcock, director of FDA's Center for Drug Evaluation and Research, clarifies FDA's role in drug pricing.
/ read more /
More Industry News
|
|
EXPERT INTERVIEW
Richard Denk, head sales containment at SKAN, spoke with Pharmaceutical Technology about trends in handling high potency APIs.
WATCH NOW |
|
|
|
|
|
Supplier News
GE Healthcare's GE BioPark Cork will hold four KUBio manufacturing facilities; GE will also collaborate with NIBRT for biopharmaceutical training.
/ read more /
The project aims to address challenges facing the development, manufacture, and delivery of vaccines.
/ read more /
More Supplier News
|
|
|
|
|
|
Bio/Pharma News
Adaptimmune entered into a manufacturing agreement with PCT for the manufacture of its SPEAR T-cell therapies.
/ read more /
Allergan will acquire Vitae pharmaceuticals for $639 million.
/ read more /
More Bio/Pharma News
|
|
|
|
|
|
Regulatory News
The agency has recommended marketing authorization for Ibrance in the European Union.
/ read more /
Industry concerns have generated efforts by FDA to streamline the system for designating the lead center to regulate a new combination product.
/ read more /
More Regulatory News
|
|
|
|
|
QUALITY
Visual inspection of parenteral vials is the first step in a root cause investigation.
/ read more /
|
|
|
|
FORMULATION
Nanoparticulate technologies are showing promising potential in delivering both small-molecule drugs and biomacromolecules across the blood brain barrier.
/ read more /
|
|
|
AAPS Planning Guide
 |
The FE75 double-sided rotary tablet press is equipped with up to 115 punch stations to produce more than 1.6 million tablets/hr.
AAPS Booth # 1133
/ Learn more / |
 |
Qualicaps is a global manufacturer of empty pharmaceutical capsules and pharmaceutical processing equipment.
AAPS Booth # 827
/ Learn more / |
 |
Lubrizol LifeSciences is a healthcare solution partner for medical and pharmaceutical manufacturers who need product development support and combination device solutions.
AAPS Booth # 1127
/ Learn more / |
|
|
|
Events
September 26–28, 2016
October 4–6, 2016
November 7–8, 2016
more events |
|
|
REFERENCE BOOKS |
 |
Increase your knowledge of solid dosage technology and solid dose tablet manufacturing processes. These comprehensive pharmacology reference guides cover a variety of solid-dosage form principles such as oral solid-dosage forms, powders, mixing and blending, excipients, tableting, and coating. Drug delivery system manufacturing professionals can use the solid dosage manufacturing books to stay current with compressed tablet manufacturing processes, solid dosage processing equipment, tablet-pressing processes, and pharmaceutical industry trends in oral solid dosage manufacturing and solid dosage form development.
/ Click here /
More Reference Library |
|
|
|
eBOOKS
 |
Read feature articles on accelerated scale-up for vaccine production, standards for air cleanliness classification, aseptic filling advances, a flexible approach to cleanroom design, a science-driven approach for microbial control, removing genotoxic impurities, regulatory enforcement, drug shortages, and validation of single-use shipping systems. |
|
|
|
|
|
